Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript Motley Fool - Wed May 8, 3:45PM CDT

KPTI earnings call for the period ending March 31, 2024.

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics: Q1 Earnings Snapshot AP - Wed May 8, 6:41AM CDT

Karyopharm Therapeutics: Q1 Earnings Snapshot

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript Motley Fool - Thu Feb 29, 5:15PM CST

KPTI earnings call for the period ending December 31, 2023.

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics: Q4 Earnings Snapshot AP - Thu Feb 29, 6:50AM CST

Karyopharm Therapeutics: Q4 Earnings Snapshot

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript Motley Fool - Thu Nov 2, 2023

KPTI earnings call for the period ending September 30, 2023.

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 2, 2023

Karyopharm Therapeutics: Q3 Earnings Snapshot

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 0.8029 (-3.05%)
Karyopharm to Present Selinexor Data at the 2023 International Myeloma Society Annual Meeting and European Society of Gynaecological Oncology 2023 Annual Meetings PR Newswire - Tue Sep 26, 2023

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 0.8029 (-3.05%)
Karyopharm to Participate at Upcoming Investor Conferences PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 0.8029 (-3.05%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Fri Sep 1, 2023

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 0.8029 (-3.05%)

Barchart Exclusives

RSI Oversold: 2 Stocks (HOWL, WKHS) Potentially Signaling a Contrarian Buy Barchart - Fri Jul 5, 8:45AM CDT
Sometimes equities that have been pushed too far down are at risk of surprisingly bouncing back. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot